Diagmmr®

FROM SAMPLE TO DIAGNOSIS

DiagMMR® is designed to be a predictive diagnostic tool that enables preventive follow-up and counselling for affected mutation carriers who are at high risk for developing Lynch syndrome related cancers.

While current Lynch syndrome diagnosis relies heavily on tumor studies, the quantitative DiagMMR® method allows carrier diagnosis based on a non-invasive tissue sample before the person has developed any cancer, without the knowledge and details of an inherited mutation.

The inherent challenges to variant interpretation in genetic testing can be avoided and the conclusive and actionable results removes the burden of uncertainty from both the patients and the treating mdeical professionals.

DiagMMR Laboratory

DIAGNOSTIC BENEFITS

DiagMMR® innovation has several outstanding benefits compared to the current diagnostic tools:
DiagMMR Workflow